MUMBAI, India, Sept. 5 -- Intellectual Property India has published a patent application (202441015320 A) filed by Difgen Pharmaceuticals Pvt. Ltd., Hyderabad, Telangana, on March 1, 2024, for 'morphologically directed raman spectroscopy (mdrs) for analysing the particle size and shape of tobramycin and dexamethasone.'
Inventor(s) include Dipak Chandrakant Kulkarni; Nithun Saha; and Gaurav Jain.
The application for the patent was published on Sept. 5, under issue no. 36/2025.
According to the abstract released by the Intellectual Property India: "The present invention discloses development of a Morphologically Directed Raman Spectroscopy (MDRS) analytical method for analyzing the particle size and shape of the constituents of the product, which contains a blend of two active pharmaceutical ingredients (APIs); Tobramycin and Dexamethasone."
Disclaimer: Curated by HT Syndication.
